Recently adopted names for antitumoral compounds (September 2012) - Noms d’antitumoraux adoptés récemment (septembre 2012)

Name (nom)	Code name	Type	Target(s)
Aldoxorubicin hydrochloride	INNO-206	An albumin-binding doxorubicin prodrug	DNA intercalator
Entilomod	CBLB502	Protein	Radiation countermeasure drug
Nelipepimut-S (NeuVax)	E75 peptide	Peptide (vaccine)	HER2/neu
Pimasertib	MSC1936369A; AS703026; EMD 1036239	Synthetic small molecule inhibitor	MEK1
Ramucirumab	IMC-1121B	Monoclonal antibody	VEGFR-2
Rebastinib tosylate	DP-1919.TO, DCC-2036	Synthetic small molecule inhibitor	Multiple tyrosine kinases